Clomiphene, hCG & FSH for Male Fertility
Off-label SERMs and gonadotropins to preserve or restore spermatogenesis
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Clomiphene FDA-approved for female anovulation (off-label in men); hCG approved for hypogonadotropic hypogonadism; FSH products approved in specific contexts
Reference only. Not medical advice.
What can go wrong
These are off-label in men (clomiphene especially), with variable response and incomplete long-term safety data; reported effects include visual changes and mood/libido effects (clomiphene), and the need for monitoring. They are not magic for severe testicular failure. The marketplace risk is mirror-image of TRT: clinics that profit from testosterone may underuse fertility-sparing options, while others may overprescribe SERMs/hCG with thin monitoring.
This is something to take to a clinician. The Atlas can tell you what is known about clomiphene, hcg & fsh for male fertility in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Clomiphene citrate (a SERM), human chorionic gonadotropin (hCG, an LH analog), and FSH (recombinant or hMG) are used off-label to raise endogenous testosterone and preserve or restore sperm production - critically, without the spermatogenic shutdown that exogenous testosterone causes. They are central to managing hypogonadism in men who want fertility and to restarting sperm production after TRT or anabolic steroid use. The off-label prescribing economics are significant and increasingly telehealth-driven.
The fertility-sparing alternative TRT clinics rarely lead with.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Clomiphene/enclomiphene block estrogen receptors at the hypothalamus, removing negative feedback so the pituitary secretes more LH and FSH, raising intratesticular testosterone and supporting spermatogenesis. hCG directly stimulates Leydig-cell LH receptors, maintaining the high intratesticular testosterone that sperm production requires. FSH (recombinant or hMG) supports Sertoli-cell function and is added when FSH is low or response is inadequate. Unlike exogenous testosterone, none of these shut down the testis.
What it does to fertility
These agents are specifically used to preserve or restore fertility, in contrast to exogenous testosterone which suppresses spermatogenesis and can cause azoospermia.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Serum total/free testosterone and estradiol
- LH and FSH
- Semen analysis to track spermatogenesis
- Hematocrit and lipid panel (clomiphene)
- Visual symptoms (clomiphene)
What people get wrong
Often saidTRT and fertility are compatible if you just lower the dose
ActuallyAny exogenous testosterone suppresses the HPG axis; preserving fertility generally requires fertility-sparing agents (clomiphene/enclomiphene/hCG), not merely a lower testosterone dose.
Often saidClomiphene is FDA-approved for men
ActuallyIt is approved for female anovulation and used off-label in men; enclomiphene was studied but not approved for this indication.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Clomiphene entered medicine in the 1960s for female ovulation induction; andrologists adopted it off-label for male hypogonadism and idiopathic infertility over subsequent decades. hCG has long treated hypogonadotropic hypogonadism. The TRT boom of the 2010s, and the recognition that testosterone sterilizes, revived interest in fertility-sparing alternatives - amplified by direct-to-consumer telehealth.
- 1960sClomiphene approved for female anovulation
- 2000s-2010sOff-label clomiphene/hCG popularized for male hypogonadism and TRT fertility-sparing
- 2010sEnclomiphene studied as a sperm-preserving testosterone therapy; not approved
- 2020sTelehealth scales off-label SERM/hCG prescribing
Set against the alternatives
Versus TRT, these agents preserve fertility but produce a more variable testosterone response and require functioning testes. hCG restarts faster and more directly than clomiphene; FSH is additive. For pure replacement without fertility goals, TRT is simpler; for fertility, the SERM/gonadotropin route is preferred.
What we do not know
- Do clomiphene/enclomiphene improve live-birth rates, or mainly serum testosterone and sperm counts?
- What is the long-term safety of chronic off-label SERM use in men?
- Will enclomiphene ever gain a formal approval, or remain a compounded gray-market product?
At a glance
- Exogenous T effect
- suppresses LH/FSH and can cause azoospermia in months
- Clomiphene mechanism
- blocks hypothalamic estrogen feedback, raising LH/FSH
- hCG
- mimics LH, drives intratesticular testosterone and sperm
- Use case
- fertility-preserving alternative to TRT; post-cycle restart
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Clomiphene, hCG & FSH for Male Fertility. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Clomiphene for male hypogonadism cohorts2010s
Raised serum testosterone and often maintained sperm parameters in many men, though RCT-grade fertility-outcome data are limited
hCG co-administration with TRT2013 (Hsieh et al.) and others
Low-dose hCG alongside testosterone helped preserve intratesticular testosterone and spermatogenesis
Enclomiphene trials2010s
Raised testosterone while preserving sperm counts better than topical testosterone in comparative studies; a formal FDA approval was not secured